Clinical Science and Epidemiology

Jessica Tangren Renal circulatory adaptation in pregnancy; AKI/CKD and pregancy outcomes

Anna Greka New treatments in Glomerular Kidney diseases John Niles Define the role of tests for ANCA in the evaluation of pulmonary hemorrhage syndrome Meghan Sise Clinical trials in glomerular diseases, study of viruses and the kidney

Shruti Gupta Nephrotoxicity of oncologic therapies Meghan Sise Acute and chronic kidney disease in patients treated with immunotherapy, CAR-T and targeted agents for cancer

Gary Curhan Risk factors and multi-omics approach to prevention of kidney stones Julie Paik Risk factors for fractures

Gearoid McMahon Perform research kidney biopsies in patients with CKD to create a new atlas of kidney disease Matt Sampson Genomic literacy in nephrology, translating genomic discovery to genomic medicine Sahir Kalim Protein and metabolite alterations in uremia

John Forman Effects of Melatonin on Cardiometabolic risks, Physiological mechanisms of Hypertension

Ethics in Nephrology Valerie Luyckx Ethics of ESRD care Ernest Mandel Resource allocation in AKI and ESRD care Global Health in Nephrology Valerie Luyckx Kidney disease management in low- and middle-income countries Mohammed Sayegh Conflict and disaster nephrology: ESRD care in refugee and other stressed populations Population Health Management Li-Li Hsiao Community outreach and education programs (KDSAP) Mallika Mendu Development of network-wide CKD registry, population health-based innovations to improve care delivery Quality and Safety Mallika Mendu Care delivery innovation research to improve quality and safety for kidney disease patients

Anna Greka Abatacept in Treatment Resistant Nephrotic Syndrome Gearoid McMahon ASCEND: Trial of prolyl hydroxylase inhibitors in patients with CKD and ESRD John Niles Avacopan in C3GN; MAINTANCAVAS: Maintenance treatment in ANCA vasculitis Nina Tolkoff-Rubin Eculizumab for recurrent aHUS post transplant Leonardo Riella Novel drug targets and dietary interventions to promote immune regulation in humans Ajay Singh ASCEND Clinical development program - a phase 3 program for the development of a novel propyl hydroxylase inhibitor Daprodustat. Meghan Sise Clinical trials in Hepatitis C virus infection and HCV+ to HCV-naive kidney transplantation

Andrew Allegretti Hepatorenal Syndrome, AKI in cirrhosis Joseph Bonventre Mechanisms of AKI and AKI to CKD transition with discovery of new therapeutics Kenneth Christopher Critical Care Metabolomics Shruti Gupta Outcomes of COVID-19 in critically ill patients David Leaf Identifying novel risk factors and mechanisms of AKI, and therapies for its prevention and treatment Mallika Mendu Implementation of a standarized algorithim related to RRT initiation and catheter placement (AKI SCAMP)

Anemia and Iron in CKD Finnian McCausland Trajectory of hemoglobin changes during CKD, risk factors for anemia, and the association of hemoglobin with outcomes Ajay Singh Development of new anemia treatments in patients with kidney disease Cardiovascular Disease in CKD Finnian McCausland Cardio-renal interactions and risk factors for heart failure and CKD progression - observational studies and interventional trials Dialysis Sahir Kalim Protein carbamylation, amino acid balance, and uremic toxins in CKD Finnian McCausland Modifiable risk factors for intra-dialytic hypotension and cardiovascular disease in hemodiaysis - observational studies and interventional trials Geriatric Nephrology and Palliative Care Sahir Kalim Chronic pain and [...]